CARB-X supports BioVersys in the fight against antimicrobial resistance with up to almost 9 million dollars
BioVersys receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies:
Monte Rosa Therapeutics raises $95M in series C funding roun...
Cellestia - a leading pioneer in modulating gene expression ...
Bottneuro among Forbes “30 Spin-offs To Watch 2021 DACH”
10 Jahre Technologiepark Basel – Treiber der Innovation
Kinarus appoints Thierry Fumeaux, MD, as Chief Medical Offic...